Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's lymphoma: the pathologist's viewpoint.

S A Pileri1, S Ascani, L Leoncini

  • 1Pathologic Anatomy and Haematopathology, Bologna University, Policlinico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy. pileri@almadns.unibo.it

Journal of Clinical Pathology
|March 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous involvement in multiple myeloma. A rare entity.

Clinical case reports·2025
Same author

Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

BCL-2 expression in primary cutaneous follicle center lymphoma is associated with a higher risk of cutaneous relapses: A study of 126 cases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Who is the culprit? A toxic epidermal necrolysis case in a patient treated with rituximab plus polatuzumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Recent Hodgkin

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Hodgkin's lymphoma (HL) research has advanced understanding of its phenotype, molecular features, and lymphomagenesis.
  • Consensus exists on B cell origin in most HL cases, with Epstein-Barr virus and defective cytokinesis implicated in some patients.
  • The REAL/WHO classification distinguishes lymphocyte predominance HL (LP-HL) from classic HL (CHL) subtypes based on clinical, morphological, and molecular differences.

Purpose of the Study:

  • To elucidate the updated understanding of Hodgkin's lymphoma phenotype, molecular characteristics, and lymphomagenesis.
  • To clarify the classification and distinctions between Hodgkin's lymphoma subtypes and related lymphomas.
  • To explore the development of tailored treatments based on tumor pathobiology.

Main Methods:

Related Experiment Videos

  • Review of recent research on Hodgkin's lymphoma phenotype and molecular characteristics.
  • Analysis of classification systems (REAL/WHO) for Hodgkin's lymphoma subtypes.
  • Evaluation of proposed treatment strategies adjusted to tumor pathobiology.

Main Results:

  • Established B cell derivation in most Hodgkin's lymphoma cases.
  • Identified Epstein-Barr virus and defective cytokinesis as relevant factors in a subset of patients.
  • Refined distinctions between classic HL subtypes and clarified boundaries with other lymphomas like anaplastic large cell lymphoma and T cell rich B cell lymphoma.

Conclusions:

  • Hodgkin's lymphoma understanding has significantly advanced, revealing B cell origins and key pathogenetic factors.
  • The classification system effectively differentiates HL subtypes, though some distinctions remain challenging.
  • Personalized treatment strategies for Hodgkin's lymphoma are emerging, tailored to specific pathobiological features.